Daewoong manufactures and supplies drugs for anti-anemic agents and joint diseases. Read more

234 Followers on Owler
234 Followers on Owler
234 Followers on Owler
234 Followers on Owler

Daewoong manufactures and supplies drugs for anti-anemic agents and joint diseases. Read more

Sengho Jeon's photo - CEO of Daewoong

CEO

Sengho Jeon

CEO Approval Rating

74/100

Founded:

06/1945

Status:

PublicIndependent CompanyKorea Exchange069620

Annual Revenue
Employees
Sector

- -

TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

Hanmi Pharm is seen as one of Daewoong's top competitors. Hanmi Pharm was founded in 1973, and is headquartered in Songpa-gu, Seoul Teugbyeolsi. Hanmi Pharm operates in the Pharmaceuticals industry. Hanmi Pharm generates $117.1M more revenue vs. Daewoong.

Petrofac is a top competitor of Daewoong. Petrofac was founded in 1981, and its headquarters is in St Helier, Other. Petrofac competes in the Oil & Gas Equipment & Services industry. Petrofac has 10,019 more employees than Daewoong.

Donga is Daewoong's #3 rival. Donga was founded in Orlando, Florida} in null. Donga is in the Publishing field. Compared to Daewoong, Donga generates $839.6M less revenue.

Weigh-in!

Help the Owler community know more

Competitor - 1/1

Is TechnipFMC a competitor of Daewoong?

Quarterly and Annual Revenue

Coming soon for Daewoong!

Annual Revenue

$844.6M

Daewoong's revenue is the ranked 13th among it's top 10 competitors. The top 10 competitors average 4.7B.

Acquisitions

No recent acquisitions found related to Daewoong

Daewoong Funding History

No recent funding data found related to Daewoong

Investments

COMPANY

DESCRIPTION

AMOUNT

INVESTMENT DATE

ROUND

EXIT DATE

AEON Biopharma is a biotechnology company that researches and develops botulinum toxin for the treatment of debilitating medical conditions.
$25M
Sep 01, 2020
Convertible Note
-
Evolus is a performance beauty company that offers medical aesthetics products and treatments.
$40M
Jul 05, 2020
Convertible Note
Feb 07, 2018

Daewoong News

January 14, 2021Korea Biomedical Review

Daewoong, Medytox to continue legal battle over BTX strain

The U.S. International Trade Commission (ITC) Thursday released the full document of its final ruling... See more »
January 7, 2021Korea Biomedical Review

Daewoong wins most nods for P3 trial among Korean drugmakers

Daewoong Pharmaceutical received approvals for eight phase 3 clinical trials last year, beating all o... See more »
January 4, 2021The Korea Herald

Daewoong to initiate phase 3 trial of camostat in combination with remdesivir

Daewoong Pharmaceutical's pancreatitis treatment Foistar (DWJ1248) is to enter a new phase 3 clinical... See more »
December 31, 2020Korea Biomedical Review

Daewoong to start P3 trials of gastric acid blocker in China

Daewoong Pharmaceutical said that China's National Medical Products Administration (NMPA) has approve... See more »
December 22, 2020Korea Biomedical Review

Daewoong proves Nabota's potency in various temperature

Daewoong Pharmaceuticals said Tuesday it has confirmed the potency stability of its botulinum product... See more »
December 21, 2020The Korea Bizwire

Daewoong Pharmaceutical Eyes COVID-19 Treatment's Launch Early Next Year

SEOUL, Dec. 21 (Korea Bizwire) - South Korean drugmaker maker Daewoong Pharmaceutical Co. aims to lau... See more »
December 17, 2020The Korea Herald

Daewoong Pharmaceutical's Nabota banned in US for 21 months

A US trade court ruled Wednesday in favor of Medytox in its 5-year-old legal battle with Daewoong Pha... See more »

Daewoong Press Releases

July 9, 2019PR Newswire Asia

Daewoong Pharmaceutical participated in the IMCAS Asia 2019 to introduce the excellence of BEAUTEM

BALI, Indonesia and SEOUL, South Korea, July 9, 2019 /PRNewswire/ -- Daewoong Pharmaceutical Co., Ltd... See more »
February 22, 2018Industry Today

Gastric Ulcers Market Key Players - Astellas Pharma Inc, Boryung Pharmaceutical Co Ltd, ChoDang Pharm Co Ltd and Daewoong Pharmaceutical Co Ltd Analysis & Forecast 2017 to 2022

WiseGuyReports.com with their unique quality of simplifying the market research study, presents a dee... See more »
February 12, 2018EIN Presswire

Alopecia Professional Survey about Therapeutics and Pipeline Review H1 2018

PUNE, MAHARASHTRA, INDIA, February 12, 2018 /EINPresswire.com/ -- WiseGuyReports.com with their uniqu... See more »
September 11, 2017BriefingWire

Cholelithiasis Global Clinical Trials Review H1 2017

ReportsWeb.com published "Cholelithiasis Market" from its database. The report covers the market land... See more »
November 3, 2016NewsMaker

Postherpetic Neuralgia 2016 Pipeline Review Therapeutics Drugs Profile and Key Companies Analysis

Latest Postherpetic Neuralgia Pipeline Review, H2 2016, provides in depth analysis on Cellular Tumor ... See more »
September 20, 2016NewsMaker

Global Nonalcoholic Fatty Liver Disease Industry, Analysis, Research, Trends, Growth to 2016

MarketStudyReport.com adds "Global Nonalcoholic Fatty Liver Disease Market Research Report 2016" new ... See more »
September 19, 2016NewsMaker

Daewoong Pharmaceutical Co., Ltd Therapeutic landscape And Targeted Therapy Areas Pipeline Review H2 2016

Daewoong Pharmaceutical Co., Ltd Market 2016...... See more »

Social Media

Headquarters

12, Bongeunsa-ro 114-gil, Gangnam-gu

Seoul, Seoul Teugbyeolsi135-715

82-2-550-8382

Driving Directions »

Trending Companies

Summary

ABOUT

Overview

Daewoong manufactures and supplies drugs for anti-anemic agents and joint diseases. Daewoong was founded in 06/1945. Daewoong's headquarters is located in Seoul, Seoul Teugbyeolsi, KR 135-715. Daewoong's CEO, Sengho Jeon, currently has an approval ra...

CEO

Daewoong's CEO, Sengho Jeon, currently has an approval rating of 74%. Daewoong's primary competitors are Hanmi Pharm, Petrofac & Donga.

Website

daewoong.com

Frequently Asked Questions about Daewoong

  1. When was Daewoong founded?

    Daewoong was founded in 06/1945
  2. Who is Daewoong's CEO?

    Daewoong's CEO is Sengho Jeon
  3. How much revenue does Daewoong generate?

    Daewoong generates $844.6M in revenue
  4. How much funding does Daewoong have?

    Daewoong has historically raised $0 in funding
  1. Where is Daewoong's headquarters?

    Daewoong's headquarters is in Seoul Seoul Teugbyeolsi, KR
  2. How many employees does Daewoong have?

    Daewoong has 1,481 employees
  3. Who are Daewoong's competitors?

    Daewoong's top competitors are Hanmi Pharm, Petrofac, Donga
  4. Who has Daewoong invested in?

    Daewoong's has invested in companies such as AEON Biopharma, Evolus